Contactless Vital Signs Measurement Study (CVMS)

Status Recruiting

Clinical Trial Summary

This study asks the question - Can vital signs be accurately measured via a contactless device and can this be independently done by inpatients in their homes? Primary objectives are to validate the accuracy of contactless vital sign measurements in comparison with vital signs measurements of heart rate, oxygen saturation, temperature using standard ward equipment (the reference standard).

Clinical Trial Description

'Vital signs' such as heart rate (HR), temperature and peripheral blood oxygen saturation (SpO2) are routinely measured four times a day amongst hospitalised patients. However, this frequency of monitoring is unable to be replicated amongst patients in the RMH@Home Acute program. Also known as Hospital In The Home (HITH), RMH@Home Acute nurses and doctors deliver treatments to patients at home in substitution for a hospital admission. Home-based reviews are conducted one to two times daily, with more frequent reviews limited by travelling times and geographical constraints. Accordingly, this study aims to investigate the accuracy and user-friendliness of new contactless technology to measure patients 'vital signs', paving the way towards enabling home-based patients to independently measure their vital signs during their admission. Besides enabling increased frequency of routine monitoring, this technology can also be applied to improve ad hoc assessments when patients report clinical concerns by enabling vital signs to be remotely measured by patients and/or their carers whilst clinicians travel to their homes to deliver treatment. Results from publication of this study will add to lexicon of knowledge regarding the utility of remote monitoring devices in monitoring and detecting clinical deterioration amongst hospitalized patients at home. In this two-stage study, participants' vital signs obtained by the new contactless sensor are first compared with standard vital sign measurements obtained by nursing staff on the hospital ward. Should the sensor be found to obtain similar measurements thus indicating accuracy and feasibility of use amongst hospital patients, the second stage of this study involves investigating the feasibility of participants utilising these devices to measure their vital signs in the home-setting. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05886686
Study type	Observational
Source	Melbourne Health
Contact	Research Officer
Phone	61393428530
Email	research@mh.org.au
Status	Recruiting
Phase
Start date	April 5, 2023
Completion date	September 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05908045` - Have Physical Therapists Attitudes and Beliefs Towards Vital Assessment Changed Following the COVID-19 Pandemic?
Enrolling by invitation	`NCT05975658` - WIReD: Wireless Interstage Remote Device Study
Completed	`NCT03143062` - The National Early Warning Score: Preceding Dynamics in the Score for Those Who Suffer an In-hospital Cardiac Arrest
Completed	`NCT03179267` - Detection of Deterioration by SNAP40 Versus Standard Monitoring in the ED	N/A
Not yet recruiting	`NCT05023356` - Non-contact Vital Signs Monitoring in Anesthesia
Recruiting	`NCT05970614` - The Effect of Eye Masks and Earplugs In Intensive Care Unit Patients	N/A
Completed	`NCT01448161` - A Machine Learning Approach to Continuous Vital Sign Data Analysis
Recruiting	`NCT05013411` - Rethinking Observations in Mental Health
Completed	`NCT04678050` - Dexmedetomidine Compared to Ketofol for Sedation in Paediatrics	Phase 1
Not yet recruiting	`NCT04976907` - Peri-operative Mobile Application for Contactless Screening and Vital Signs Measurement
Completed	`NCT01157832` - Evaluation of the Acute Effect of Water-Pipe Smoking on the Respiratory System	N/A
Completed	`NCT04003662` - Vital Sign Comparison Between Lifelight and Standard of Care - Development
Recruiting	`NCT05241483` - Remote Patient Monitoring and Detection of Possible Diseases With Artificial Intelligence Telemedicine System
Not yet recruiting	`NCT04627766` - Validation of Continuous Monitoring of Vital Signs in Children With a Connected Patch	N/A
Completed	`NCT04997694` - Effect of Preoperative Active Warming and Passive Warming Methods on Perioperative Hypothermia	N/A
Active, not recruiting	`NCT04935190` - Comparison of Resting Heart and Respiratory Rate Measurements Acquired by Contactless Radar Sensors, Electrocardiography, and Capnography
Completed	`NCT04935723` - The Effects of Reiki on Abdominal Surgery Patients' Anxiety, Fear, Postoperative Pain and Life Findings	N/A
Not yet recruiting	`NCT06427564` - Vital Signs Collection Via "Comestai" App
Completed	`NCT05131620` - Virtual Reality and Acupressure Applications; Effect on Pain, Anxiety, Vital Signs and Comfort	N/A
Completed	`NCT02524470` - Vital Signs Patch Early Feasibility and Usability Study v1.0	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Contactless Vital Signs Measurement Study (CVMS) — CVMS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms